<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    electroCore, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About electroCore, Inc.

    electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company’s current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $426,000,000
    • SIC CODE
      3845
    • NIN CODE
      ####
    • LEADERSHIP
      Francis R. Amato
    • FOUNDED
      2005
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Axovant Gene Therapies Ltd.

    Axovant Gene Therapies Ltd.

    Axovant is accelerating the development of innovative gene therapy products that a...

    Axovant is accelerating the development of inno...

    Filing Type:    PU
    MedAnswers

    MedAnswers

    With 40 million infertile people worldwide, MedAnswers connects patients with mult...

    With 40 million infertile people worldwide, Med...

    Amount Raised:    $145,702.50
    Fundraising Status:    EC
    Filing Type:    CF
    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company committing...

    Pieris Pharmaceuticals, Inc. is a, clinical-sta...

    Filing Type:    PU
    argenx SE

    argenx SE

    argenx is a clinical-stage biotechnology company developing a deep pipeline of dif...

    argenx is a clinical-stage biotechnology compan...

    Filing Type:    PU
    Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focu...

    Anthera Pharmaceuticals, Inc., a development st...

    Amount Raised:    $65,500,000
    Fundraising Status:    VT
    Filing Type:    PU
    AdaptHealth Corp.

    AdaptHealth Corp.

    We are a network of full-service medical equipment companies that use tailored pro...

    We are a network of full-service medical equipm...

    Filing Type:    PU
    NeuroMetrix, Inc.

    NeuroMetrix, Inc.

    Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and ...

    Founded in 1996 as a spinoff from the Harvard-M...

    Filing Type:    PU
    Sorrento Therapeutics, Inc.

    Sorrento Therapeutics, Inc.

    Sorrento’s lead programs with short-term milestones consist of two clinical stag...

    Sorrento’s lead programs with short-term mile...

    Filing Type:    PU
    Sanofi

    Sanofi

    Sanofi is dedicated to supporting people through their health challenges. We are a...

    Sanofi is dedicated to supporting people throug...

    Filing Type:    PU
    Chiasma, Inc.

    Chiasma, Inc.

    Chiasma is focused on improving the lives of patients who face challenges associat...

    Chiasma is focused on improving the lives of pa...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc. is a clinical stage biotechnology company developing oral ...

    Evelo Biosciences, Inc. is a clinical stage bio...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.